Project Number 18PTC-R-589358 Agency/Funding Organization Alzheimer's Association Funding Year 2018 View Full Project Details for Phase 2a Alzheimer’s trials of a novel neurotrophic activator, NDX-1017. Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) r. Multi-target Researcher and Organization Principal Investigator Hua, Xue Principal Investigator First Name Xue Principal Investigator Last Name Hua Awardee Organization Athira Pharma, Inc. Awardee State Washington Contact PI Country United States Project Detail Funding Opportunity Announcement PA 2018: PTC-R RFA FY Overall Cost $1,000,000 Funding Organization Agency/Funding Organization Alzheimer's Association Funding Organization Country United States Program Official Snyder, Heather hsnyder@alz.org
